The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes (Q56985191)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

microvasculature remodeling

24 February 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Luca Madaro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Carmine Nicoletti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Luigi Zezza

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

Speranza Donatella Rubattu

24 February 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

Speranza Donatella Rubattu

24 February 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Dominik N. Muller

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Massimo Volpe

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

8

Alessandro Alonzo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Emanuele Arrabito

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Rosa Parente

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Lidia Sada

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Serena Michelini

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

1 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

183-189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

Angiotensin II and the vascular phenotype in hypertension

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

From evidence to rationale: cardiovascular protection by angiotensin II receptor blockers compared with angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Effects of antihypertensive therapy on hypertensive vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Are there effects of renin-angiotensin system antagonists beyond blood pressure control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Pharmacology of renin inhibitors and their application to the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Direct renin inhibition: from pharmacological innovation to novel therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Countervailing vascular effects of rosiglitazone in high cardiovascular risk mice: role of oxidative stress and PRMT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Effects of antihypertensive treatment on small artery remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

The assessment of endothelial function: from research into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism: implications in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Effect of captopril and enalapril on endothelial function in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Effect of AT1 receptor blockade on endothelial function in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Small artery remodeling in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Endothelial nitric oxide synthase in vascular disease: from marvel to menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Reactive oxygen species and vascular biology: implications in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

Novel drugs targeting hypertension: renin inhibitors and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120395

21 January 2018

Identifiers

DOI

10.1042/CS20120395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23438195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference